Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?

Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG; DIADS-2 Research Group.

Int J Geriatr Psychiatry. 2011 Jun;26(6):573-83. doi: 10.1002/gps.2565.

2.

Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.

Weintraub D, Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG; DIADS-2 Research Group.

Am J Geriatr Psychiatry. 2010 Apr;18(4):332-40. doi: 10.1097/JGP.0b013e3181cc0333.

3.

BDNF Val66Met genotype and 6-month remission rates in late-life depression.

Taylor WD, McQuoid DR, Ashley-Koch A, MacFall JR, Bridgers J, Krishnan RR, Steffens DC.

Pharmacogenomics J. 2011 Apr;11(2):146-54. doi: 10.1038/tpj.2010.12. Epub 2010 Mar 2.

4.

Sertraline for the treatment of depression in Alzheimer disease.

Rosenberg PB, Drye LT, Martin BK, Frangakis C, Mintzer JE, Weintraub D, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Lyketsos CG; DIADS-2 Research Group.

Am J Geriatr Psychiatry. 2010 Feb;18(2):136-45. doi: 10.1097/JGP.0b013e3181c796eb.

5.

Serotonergic system genes in psychosis of Alzheimer dementia: meta-analysis.

Ramanathan S, Glatt SJ.

Am J Geriatr Psychiatry. 2009 Oct;17(10):839-46. doi: 10.1097/JGP.0b013e3181ab8c3f.

PMID:
19910872
6.

BDNF genetic variations increase the risk of Alzheimer's disease-related depression.

Borroni B, Grassi M, Archetti S, Costanzi C, Bianchi M, Caimi L, Caltagirone C, Di Luca M, Padovani A.

J Alzheimers Dis. 2009;18(4):867-75. doi: 10.3233/JAD-2009-1191.

PMID:
19661618
7.

Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study.

Steinberg M, Shao H, Zandi P, Lyketsos CG, Welsh-Bohmer KA, Norton MC, Breitner JC, Steffens DC, Tschanz JT; Cache County Investigators.

Int J Geriatr Psychiatry. 2008 Feb;23(2):170-7.

8.

Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism.

Wilkosz PA, Kodavali C, Weamer EA, Miyahara S, Lopez OL, Nimgaonkar VL, DeKosky ST, Sweet RA.

Am J Med Genet B Neuropsychiatr Genet. 2007 Dec 5;144B(8):1054-62.

9.

Design of Depression in Alzheimer's Disease Study-2.

Martin BK, Frangakis CE, Rosenberg PB, Mintzer JE, Katz IR, Porsteinsson AP, Schneider LS, Rabins PV, Munro CA, Meinert CL, Niederehe G, Lyketsos CG.

Am J Geriatr Psychiatry. 2006 Nov;14(11):920-30.

PMID:
17068314
10.

Serotonin transporter polymorphisms and clinical response to sertraline across ethnicities.

Ng CH, Easteal S, Tan S, Schweitzer I, Ho BK, Aziz S.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jul;30(5):953-7. Epub 2006 Apr 3.

PMID:
16580768
11.

The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression.

Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM.

Neurobiol Aging. 2006 Dec;27(12):1834-7. Epub 2005 Dec 15.

PMID:
16343697
12.

The influence of Serotonin Transporter Promoter Polymorphism (SERTPR) and other polymorphisms of the serotonin pathway on the efficacy of antidepressant treatments.

Serretti A, Benedetti F, Zanardi R, Smeraldi E.

Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jul;29(6):1074-84. Review.

PMID:
15939518
13.

Clinical application of operationalized criteria for 'Depression of Alzheimer's Disease'.

Rosenberg PB, Onyike CU, Katz IR, Porsteinsson AP, Mintzer JE, Schneider LS, Rabins PV, Meinert CL, Martin BK, Lyketsos CG; Depression of Alzheimer's Disease Study.

Int J Geriatr Psychiatry. 2005 Feb;20(2):119-27.

PMID:
15660424
14.
15.

Research consent for cognitively impaired adults: recommendations for institutional review boards and investigators.

Alzheimer's Association.

Alzheimer Dis Assoc Disord. 2004 Jul-Sep;18(3):171-5.

PMID:
15494623
16.

Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response.

Tsai SJ, Cheng CY, Yu YW, Chen TJ, Hong CJ.

Am J Med Genet B Neuropsychiatr Genet. 2003 Nov 15;123B(1):19-22.

PMID:
14582140
17.

The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder.

Durham LK, Webb SM, Milos PM, Clary CM, Seymour AB.

Psychopharmacology (Berl). 2004 Aug;174(4):525-9. Epub 2003 Sep 4.

PMID:
12955294
18.

Depression in Alzheimer's disease: heterogeneity and related issues.

Lee HB, Lyketsos CG.

Biol Psychiatry. 2003 Aug 1;54(3):353-62. Review.

PMID:
12893110
19.

Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

Lyketsos CG, DelCampo L, Steinberg M, Miles Q, Steele CD, Munro C, Baker AS, Sheppard JM, Frangakis C, Brandt J, Rabins PV.

Arch Gen Psychiatry. 2003 Jul;60(7):737-46.

PMID:
12860778
20.

Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.

Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S.

JAMA. 2002 Sep 25;288(12):1475-83.

PMID:
12243634

Supplemental Content

Support Center